Fortis Healthcare stock
Price history
−11.80% over the period1 year: from ₹935.40 (November 20, 2025) to ₹825.00 (November 20, 2026), −11.80%.
Show chart data
Closing prices adjusted for splits: the last close of each month.
| Date | Close |
|---|---|
| November 20, 2026 | ₹825.00 |
| October 30, 2026 | ₹768.15 |
| September 30, 2026 | ₹770.00 |
| August 31, 2026 | ₹906.90 |
| July 31, 2026 | ₹945.00 |
| June 30, 2026 | ₹956.95 |
| May 29, 2026 | ₹928.45 |
| April 30, 2026 | ₹922.95 |
| March 30, 2026 | ₹795.00 |
| February 27, 2026 | ₹942.65 |
| January 30, 2026 | ₹851.50 |
| December 31, 2025 | ₹884.00 |
| November 28, 2025 | ₹919.10 |
| November 20, 2025 | ₹935.40 |
At a glance
The company
Operates a network of hospitals and healthcare facilities offering a comprehensive range of medical services across India
Latest results
Quarter to September 30, 2026 · EPS ₹4.10 (estimate ₹4.32)
TickerLandia's take on Fortis Healthcare
- Priced as usual relative to earnings: P/E on the latest fiscal year 60 vs a median of 53 over its last 7 fiscal years.
- Pricier than similar companies: trailing 12-month P/E 57 vs 34 (+65%) in a group of 11.
- Strong point: Growth (64/100 in its group). Weak point: Dividend (12/100).
Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks
Where the price stands
−18.32% from the 52-week high
Analysts · 20 analysts
Average target₹1,018.95+23.51% vs. price
Buy 17 · Hold 3 · Sell 0 · Strong buy
TickerLandia Fingerprint: Fortis Healthcare
Compared with similar companies: very low dividend and very high price.
Financials and price compared with 19 companies in the medical care facilities industry, worldwide. Momentum and risk compared with 1,074 Asia-Pacific stocks.
Pricevery high83
How much it costs relative to what it produces.
Metric Value Position in group Forward P/E 36.3 86 EV/EBITDA 30.1 82 Price/book 5.72 74 Price/sales 6.05 87 P/E (trailing 12 months) 56.8 86 Profitabilityaverage60
How much it earns on revenue and capital.
Metric Value Position in group Operating margin 17.1% 61 ROA 6.7% 45 Gross margin 58.6% 92 Net margin 10.5% 76 ROE 10.4% 25 Earnings stabilityaverage43
How steady its margins were over the last five annual reports.
Metric Value Position in group Margin variabilitycounts in reverse: lower means more earnings stability 2.2% 29 Loss-making yearscounts in reverse: lower means more earnings stability 0 of 5 annual reports 58 Growthhigh64
How fast revenue and earnings are growing.
Metric Value Position in group Average revenue growth (3 years) +13.17% 66 Revenue growth (year over year) +17.30% 82 Earnings growth (year over year) −2.80% 45 Financial strengthhigh60
How well it would weather a hard period: debt, liquidity, interest.
Metric Value Position in group Interest coverage 6.00 50 Current ratio 0.79 18 Net debt/EBITDAcounts in reverse: lower means more financial strength 1.51 82 Debt/equitycounts in reverse: lower means more financial strength 0.29 92 Dividendvery low12
How much it returns to shareholders, and for how long.
Metric Value Position in group Consecutive dividend years 4 years 19 Dividend yield 0.1% 3 Payout ratio 7.1% 15 Market momentumaverage40
How the stock has moved compared with the market.
Metric Value Position in group 1-year return −11.80% 31 Distance from 200-day average −7.43% 50 Risklow39
How much the price swings.
Metric Value Position in group Volatility (60 days) 33.8% 42 Maximum drawdown (12 months) 28.0% 36
Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 22, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated
Valuation
Fortis Healthcare is priced as in the past and pricier than similar companies
On the latest fiscal year's earnings (2026), Fortis Healthcare's P/E today is 59.8, in line with the median of its last 7 fiscal years (53.0; between 20.4 and 164.4 from 2017 to 2026). Fortis Healthcare's P/E (trailing 12 months): 56.8, +65% against the median of a group of 11 similar companies (34.4).
Compared with 11 similar companies
| Metric | Fortis Healthcare | Position in the group | Band |
|---|---|---|---|
| P/E (trailing 12 months) | 56.8 | High | |
| Forward P/E | 36.3 | High | |
| Operating margin | 17.1% | Middle | |
| ROE | 10.4% | Low | |
| Debt/equity | 0.29 | Low |
P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Fortis Healthcare. All multiples and dividends
TickerLandia analysisHow it is calculated
The financials
The business in numbers
Revenue
₹27.35B
Latest quarter · Q3 2026
Net income
₹3.12B
Latest quarter · Q3 2026
Quarterly net margin
11.4%
Latest quarter · Q3 2026
Numbers and valuation
Full valuation- Market cap
- ₹599.93B
- P/E
- 56.8
- EPS
- ₹13.99
- Volume
- 347.95K
- Daily trading
- €11.25M
- Dividend yield
- 0.12%
- Last ex-dividend on July 24, 2026
How Fortis Healthcare is changing
All resultsRevenue grew 17.8% a year on average over the last 5 years
Operating margin rose from 12.5% to 17.8%
Less cash than profit: free cash flow equal to 58% of net income
Returns
Fortis Healthcare returns with dividends
₹1,000 invested in Fortis Healthcare 5 years ago, on November 22, 2021, would be worth ₹3,091 today: +209.10% in total, +25.36% per year. This is the price return only: dividends are excluded.
| Period | Fortis Healthcare | ₹1,000 becomes |
|---|---|---|
| 1 month | +13.17% | ₹1,132 |
| 6 months | −15.35% | ₹847 |
| Year to date | −6.67% | ₹933 |
| 1 year | −11.71% | ₹883 |
| 3 years | +129.80% | ₹2,298 |
| 5 years | +209.10% | ₹3,091 |
| 10 years | +421.99% | ₹5,220 |
From 1 year up with dividends reinvested, before taxes; under a year price only. Calculate your investment
The chart in detail
Fortis Healthcare: technical analysis
Fortis Healthcare shows no clear trend: the price and its 50- and 200-session averages are not aligned. The price is 24.9% below its all-time closing high (₹1,097.90, October 21, 2025).
- Trend
- No clear trend
- RSI (14 sessions)
- 61
- Between 30 and 70
- vs 200-session average
- −7.43%
Active signals
Close above the high of the previous 20 sessions.
Support and resistance
Price areas where Fortis Healthcare has stopped several times in the last year. They describe the chart; they are not forecasts.
- Resistance₹940.62+14.01%8 touches, last on August 28, 2026
- Resistance₹908.85+10.16%4 touches, last on September 22, 2026
- Resistance₹877.58+6.37%3 touches, last on August 12, 2026
- Last price₹825.00
- Support₹809.30−1.90%2 touches, last on October 9, 2026
- Support₹746.57−9.51%2 touches, last on November 13, 2026
Volatility and risk
- Volatility (60 sessions, annualised)
- 33.8%
- Largest fall in the last year
- −28.02%
Close of November 20, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it
Fortis Healthcare: seasonality
Average monthly price change over 20 years
Over the last 20 years, the strongest month for Fortis Healthcare has been July: +4.66% on average, positive in 15 years out of 20. The weakest has been September: −1.81% on average, positive in 10 years out of 20. November, the current month, has been positive in 13 years out of 19 (+3.66% on average).
Show chart data
| Month | Average | Median | Positive years |
|---|---|---|---|
| January | −1.68% | −1.51% | 7 of 19 |
| February | +2.86% | −0.33% | 9 of 19 |
| March | +1.25% | +2.99% | 12 of 19 |
| April | +3.65% | +1.43% | 14 of 19 |
| May | −0.12% | −3.44% | 9 of 19 |
| June | +0.93% | +1.89% | 13 of 20 |
| July | +4.66% | +4.57% | 15 of 20 |
| August | +0.64% | −0.05% | 10 of 20 |
| September | −1.81% | −0.05% | 10 of 20 |
| October | −0.82% | −0.15% | 9 of 20 |
| November | +3.66% | +5.24% | 13 of 19 |
| December | +4.03% | +2.85% | 12 of 19 |
Price change only, dividends excluded. Past seasonality does not predict future moves.
The company
Fortis Healthcare and its competitors
With a workforce of 14,649 people, Fortis Healthcare Limited is a healthcare delivery provider active across India. Its operations span hospitals, diagnostics and day care specialty facilities, offering services from clinics to quaternary care. Its clinical areas range from cardiac science, nephrology and oncology to orthopedics, obstetrics and gynaecology, neurology and organ transplant, with additional services in dermatology, ophthalmology and radiology. The company serves patients in India, and its care covers secondary and tertiary levels, alongside clinics and ancillary services.
- Headquarters
- Gurugram, India
- Employees
- 14,649
- Founded
- 1996
- Chief executive
- Ashutosh Raghuvanshi
| Company | Market cap | Operating margin | P/E (trailing 12 months) | 6 months |
|---|---|---|---|---|
| Fortis HealthcareFORTIS | $6.47B | 17.1% | 56.8 | −15.35% |
| Ramsay Health CareRHC | $8.37B | 5.9% | 40.0 | +40.77% |
| Max Healthcare InstituteMAXHEALTH | $9.95B | 21.4% | 67.0 | +0.49% |
| Aier Eye Hospital Group300015 | $12.44B | 21.8% | 34.4 | −5.49% |
| Apollo Hospitals EnterpriseAPOLLOHOSP | $14.27B | 12.1% | 58.8 | +13.88% |
| DavitaDVA | $10.13B | 15.2% | 12.2 | −18.20% |
Same industry or related industries, similar size. Compare Fortis Healthcare with its competitors · Full profile
